You are currently viewing Healthcare Startup OurPath Rebrands itself as Second Nature

Healthcare Startup OurPath Rebrands itself as Second Nature

OurPath has been launched back in 2018 in UK as a startup that tackles diabetic problems. The platform has raised a seed round worth of $3 million by combining the health experts’ advice. The company has used that fund to launch a smartphone app containing tracking technology which helps people to lose weight and maintain healthy habits.
Recently, OurParth has announced that the company got rebranded as Second Nature along with which it has raised a Series A funding round of worth $10 million from new investors including a European insurance group and Uniqa Ventures along with the Founders of mySugr, a digital diabetes management platform acquired by Roche, a healthcare giant. Including the new funding round, the company has raised a total count of $13 million, to date.
OurPath has also secured the backing of eisting investors with the new round. The list of excisting investors includes Bethnal Green Ventures, an early-stage impact investor; Connect and Speedinvest; and two European seed funds with the participation of an individual named Taavet Hinrikus who is the founder of TransferWise.
Mike Gibbs, the Co-founder of OurPath and former healthcare strategy consultant states, “Our goal at Second Nature is to solve obesity. We need to rise above the confusing health misinformation to provide clarity about what’s really important: changing habits. Our new brand and investment will help us realize that.
OurPath is the first ‘lifestyle changing program’ introducing platform to which NHS (National Health Service) has commissioned for diabetes management. The platform has claimed that 10,000 of its customers have recorded a loss of 5.9Kg weight in a time interval of 12 weeks.
Philip Edmondson-Jones, the member of board of directors at Second Nature and Investment Manager at Beringea states, “Healthcare systems are struggling to cope with spiralling rates of obesity and associated illnesses, which are projected to cost the global economy $1.2 trillion annually by 2025. Second Nature’s pioneering approach to lifestyle change empowers people to address these conditions.

Click Here For More News and Blog